NCT07143669 2026-03-10Screening Study for KIT D816V Mutated Mast Cell Disease in Select PopulationsBlueprint Medicines CorporationRecruiting450 enrolled
NCT06612281 2024-11-14Evaluation of Gixam's Performance in a FIT Negative PopulationJubaan Ltd.Phase 2 Recruiting400 enrolled